As of Mar 16
| -0.61 / -0.73%|
The 9 analysts offering 12-month price forecasts for Agios Pharmaceuticals Inc have a median target of 80.00, with a high estimate of 91.00 and a low estimate of 66.00. The median estimate represents a -3.54% decrease from the last price of 82.94.
The current consensus among 10 polled investment analysts is to Buy stock in Agios Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.